Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer.

Ma, Jin-An; Jiang, Shun; Hu, Chunhong; Xie, Yangchun; Hou, Tao

Ma, Jin-An; Jiang, Shun; Hu, Chunhong; Xie, Yangchun; Hou, Tao.

Afiliação

Ma JA; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Jiang S; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Hu C; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Xie Y; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Hou T; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha 410011, China. Electronic address: houtao@csu.edu.cn.

Lancet Oncol ; 19(3): e125, 2018 03.

Article em En | MEDLINE | ID: mdl-29508750

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Cisplatino; Quimioterapia Adjuvante; Receptores ErbB; Gefitinibe; Humanos; Neoplasias Pulmonares; Vinorelbina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Carcinoma Pulmonar de Células não Pequenas Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google